01 / ATLAS
What it is
MOTS-C is a 16-amino-acid peptide associated with a mitochondrial DNA sequence. It is investigated as a metabolic signal. [1]
02 / ATLAS
How it works
Experiments described effects on folate and purine metabolism, with AICAR accumulation and activation of AMPK, a regulator of cellular energy balance. [1]
03 / ATLAS
What research shows
The foundational study investigated metabolism and insulin sensitivity in cells and mice. These observations do not establish efficacy for weight loss, athletic performance or longevity in humans. [1]
04 / ATLAS
Study data
Lee et al., 2015, Cell Metabolism: experimental research using cell and animal models. The insulin-resistance findings are not a clinical trial of injectable products marketed under this name. [1]
05 / ATLAS
Safety and observed adverse reactions
The FDA identifies gaps in human data and potential immune-response and impurity risks. [2]
A molecule’s natural occurrence does not guarantee the safety of administering it as an external product.
06 / ATLAS
Research status
This entry relies on predominantly preclinical evidence. Research on the natural molecule or analogues must be distinguished from validation of a particular product.
07 / REFERENCES
Studies and sources
- Lee et al. · MOTS-C and metabolic homeostasis (2015) ↗Original research · Cell Metabolism
- FDA · Safety information for MOTS-C ↗Official assessment · United States

